125 related articles for article (PubMed ID: 34837908)
1. Serum Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Level in Patients with Hepatocellular Carcinoma.
Sripariwuth E; Piwchan S; Pongcharoen S
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3521-3524. PubMed ID: 34837908
[TBL] [Abstract][Full Text] [Related]
2. Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition.
Yoshikawa M; Morine Y; Ikemoto T; Imura S; Higashijima J; Iwahashi S; Saito YU; Takasu C; Yamada S; Ishikawa D; Teraoku H; Takata A; Yoshimoto T; Shimada M
Anticancer Res; 2017 Mar; 37(3):1169-1175. PubMed ID: 28314278
[TBL] [Abstract][Full Text] [Related]
3. Loss of membranous carcinoembryonic antigen-related cell adhesion molecule 1 expression is related to decreased relapse-free survival of hepatocellular carcinoma following liver transplantation.
Sha QQ; Wei QZ; Zhu JK; Wang KX; Wang C; Liu HT; Yu WB; Li MX; Zhang GY
Chin Med J (Engl); 2012 Aug; 125(16):2841-5. PubMed ID: 22932077
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients.
Abdelgawad IA
J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496
[TBL] [Abstract][Full Text] [Related]
5. Levels of HBx, VEGF, and CEACAM1 in HBV-related hepatocellular carcinoma and their correlation with cancer prognosis.
Mao CS; Yin H; Ning HB; Peng Z; Li K; Ding GQ
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3827-3833. PubMed ID: 28975984
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients.
Hann HW; Wan S; Myers RE; Hann RS; Xing J; Chen B; Yang H
PLoS One; 2012; 7(10):e47687. PubMed ID: 23112834
[TBL] [Abstract][Full Text] [Related]
7. Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
Bihrer V; Waidmann O; Friedrich-Rust M; Forestier N; Susser S; Haupenthal J; Welker M; Shi Y; Peveling-Oberhag J; Polta A; von Wagner M; Radeke HH; Sarrazin C; Trojan J; Zeuzem S; Kronenberger B; Piiper A
PLoS One; 2011; 6(10):e26971. PubMed ID: 22066022
[TBL] [Abstract][Full Text] [Related]
8. The value of liver function tests in hepatocellular carcinoma.
Lopez JB; Balasegaram M; Thambyrajah V; Timor J
Malays J Pathol; 1996 Dec; 18(2):95-9. PubMed ID: 10879229
[TBL] [Abstract][Full Text] [Related]
9. Correlation between serum enzymes and serum unsaturated vitamin B12 binding proteins in primary liver carcinoma.
Osifo BO; Ayoola A; Parmentier Y; Gerard P; Nicolas JP
Enzyme; 1988; 39(3):161-6. PubMed ID: 2837386
[TBL] [Abstract][Full Text] [Related]
10. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
Luo H; Li C; Chen L
Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
[TBL] [Abstract][Full Text] [Related]
11. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
[TBL] [Abstract][Full Text] [Related]
12. Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer.
Zhou MQ; Du Y; Liu YW; Wang YZ; He YQ; Yang CX; Wang WJ; Gao F
BMC Cancer; 2013 Jul; 13():359. PubMed ID: 23885995
[TBL] [Abstract][Full Text] [Related]
13. Elevated alpha-fetoprotein levels in hepatocellular carcinoma.
Yao FY
Am J Gastroenterol; 1999 Nov; 94(11):3387. PubMed ID: 10566766
[No Abstract] [Full Text] [Related]
14. Serum concentration of intercellular adhesion molecule-1 in patients with hepatocellular carcinoma is a marker of the disease progression and prognosis.
Shimizu Y; Minemura M; Tsukishiro T; Kashii Y; Miyamoto M; Nishimori H; Higuchi K; Watanabe A
Hepatology; 1995 Aug; 22(2):525-31. PubMed ID: 7543436
[TBL] [Abstract][Full Text] [Related]
15. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma.
Soresi M; Cervello M; Lipani G; Carroccio A; Cartabellotta A; Marasà L; Casto C; Virruso L; Montalto G
Eur J Gastroenterol Hepatol; 1997 Aug; 9(8):805-9. PubMed ID: 9282280
[TBL] [Abstract][Full Text] [Related]
16. Validation of modified fibrosis-4 index for predicting hepatocellular carcinoma in patients with compensated alcoholic liver cirrhosis.
Kim JH; Lee M; Park SW; Kang M; Kim M; Lee SH; Kim TS; Park JM; Choi DH
Medicine (Baltimore); 2018 Nov; 97(48):e13438. PubMed ID: 30508959
[TBL] [Abstract][Full Text] [Related]
17. Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma.
Yu H; Yu J; Ren Y; Yang Y; Xiao X
PLoS One; 2016; 11(4):e0153601. PubMed ID: 27074014
[TBL] [Abstract][Full Text] [Related]
18. A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.
El-Serag HB; Kanwal F; Davila JA; Kramer J; Richardson P
Gastroenterology; 2014 May; 146(5):1249-55.e1. PubMed ID: 24462733
[TBL] [Abstract][Full Text] [Related]
19. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
[TBL] [Abstract][Full Text] [Related]
20. Assay of serum CEACAM1 as a potential biomarker for breast cancer.
Yang C; He P; Liu Y; He Y; Yang C; Du Y; Zhou M; Wang W; Zhang G; Wu M; Gao F
Clin Chim Acta; 2015 Oct; 450():277-81. PubMed ID: 26343926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
